N-皮考林酰肼及其双核钯配合物的晶体结构和荧光性质

合成了配体N-皮考林酰肼(简写为Hphz)及其双核钯配合物[Pd₂(phz)₂Cl₂]. X射线衍射实验结果表明, 配体和配合物晶体均属于单斜晶系, 空间群分别为C 2/c和P 2₁/c, 分子式分别为C₆H₇N₃O和C₁₂H₁₂Cl₂N₆O₂Pd₂. 晶体学参数, Hphz, a＝1.9245(2) nm, b＝0.38927(2) nm, c＝1.8073(2) nm, b＝107.255(2)°, V＝1.2931(2) nm³, Z＝8, D_c＝1.409 Mg/m³, F(000)＝576, μ(Mo Kα)＝0.102 mm^－1, R＝0.0541, wR＝0.1762; [Pd₂(phz)₂Cl₂], a＝1.48274(9) nm, b＝1.44797(9) nm, c＝0.73951(5) nm, b＝92.719(3)°, V＝1.5860(2) nm³, Z＝4, D_c＝2.329 Mg/m³, F(000)＝1072, μ(Mo Kα)＝2.62 mm^－1, R＝0.0262, wR＝0.0555. 在配合物[Pd₂(phz)₂Cl₂]分子内, 两个钯(II)原子, 均呈畸变的N₃Cl平面正方形配位构型, 晶体内通过分子间氢键N—H…Cl 作用形成一维链状结构, 分子间吡啶环存在相互作用. 量子化学从头算方法计算结果表明, 分子内及分子间的金属钯之间也存在相互作用. 红外光谱表明, 配体在形成配合物后, ν(C＝O)和ν(C＝N)红移, ν(C—N)蓝移, 荧光光谱表明, 配合物金属对配体n-π*激发(310 nm)引起的发射峰有较大的影响.     

手性3,5-二甲基-2-芳基-2-吗啉醇盐酸盐的合成及其晶体结构

以(S)-2-氨基丙醇为手性源与α-溴-3-氯苯丙酮反应, (R)-2-氨基丙醇为手性源与6-甲氧基-2-(2-溴丙酰基)萘反应, 分别合成了手性纯化合物(2R,3R,5S)-3,5-二甲基-2-(3-氯苯基)-2-吗啉醇盐酸盐(4a)和(2S,3S,5R)-3,5-二甲基-2-(6-甲氧基-2-萘基)-2-吗啉醇盐酸盐(4b), 利用X射线单晶衍射仪测定了两化合物的晶体结构和两化合物的空间结构, 并初步分析两化合物空间结构, 化合物4a晶体属正交晶系, 空间群为P2₁2₁2, 晶胞参数为: a＝0.8718(2) nm, b＝0.7883(2) nm, c＝2.0247(6) nm, Z＝4, V＝1.3915(7) nm³, D_c＝1.328 g/cm³, F(000)＝584, R₁＝0.0399, wR₂＝0.0797, S＝1.042. 化合物4b晶体属正交晶系, 空间群为P2₁2₁2₁, 晶胞参数为: a＝0.71035 (9) nm, b＝0.77703(10) nm, c＝2.9820(4) nm, Z＝4, V＝1.6318(4) nm³, D_c＝1.318 g/cm³, F(000)＝688, R₁＝0.0520, wR₂＝0.1108, S＝0.994.     

IIB族金属二硫代氨基甲酸配合物的合成、表征及热稳定性研究

在甲醇溶液中合成了一系列IIB过渡金属Zn(II), Cd(II)的二羟乙基二硫代氨基甲酸[(EtOH)₂dtc]的配合物, 并对配合物M[(EtOH)₂dtc]₂L [M＝Zn (1), Cd (2), L＝2,2'-联吡啶; M＝Zn (3), Cd (4), L＝邻菲啰啉]进行了红外光谱、元素分析、热重分析表征工作. 热重分析表明配合物1～4中DTC配体比中性配体更易失去, 热分解最终产物为相应的氧化物. 对化合物1, 2做了X-ray单晶衍射分析, 1为单斜晶系, P2₁/c空间群, 晶胞参数a＝0.72146(5) nm, b＝2.61720(18) nm, c＝1.59438(11) nm,b＝97.899(2)°, V＝2.9820(4) nm³, Z＝4, m＝1.133 mm^－1, D_c＝1.297 Mg•m^－3; 2为三斜晶系, P-1空间群, 晶胞参数a＝1.0075(2) nm, b＝1.1580(2) nm, c＝1.1777(2) nm, a＝70.92(3)°, b＝85.71(3)°, γ＝81.02(3)°, V＝1.2822(4) nm³, Z＝2, m＝2.118 mm^－1, D_c＝1.630 Mg•m^－3.     

四-(p-羟基苯基)杯[4]间苯二酚芳烃的烃基化和酰胺化反应

间苯二酚和对羟基苯甲醛在盐酸/乙醇中缩合生成四-(p-羟基苯基)杯[4]间苯二酚芳烃(1), 在K₂CO₃/丙酮体系中将1分别与溴乙酸乙酯、溴丙烯、N,N-二丙基氯乙酰胺反应可得到全氧烃基化产物2a～2c. 含有12个乙氧基羰基甲氧基支链的2a被苯乙胺、N,N-二甲基二丙胺或三乙烯四胺直接胺解生成杯[4]间苯二酚芳烃酰胺衍生物3a～3c. 2a经过碱性水解、酰氯化、胺化反应转化为含吡啶基的酰胺衍生物3d. 化合物结构都用¹H NMR, IR和元素分析等方法进行了表征.     

1-(2,6-二氯-4-三氟甲基苯基)-3-氰基-5-氨基吡唑及其酰胺、二酰亚胺的合成及晶体结构

2,6-二氯-4-三氟甲基苯胺经重氮化后与2,3-二氰基丙酸酯反应合成了1-(2,6-二氯-4-三氟甲基苯基)-3-氰基-5-氨基吡唑(1), 1与乙酸酐、顺丁烯二酸酐、苯甲酰氯反应得到1的乙酰胺2a、顺丁烯酰亚胺2b和苯甲酰胺2c. 通过元素分析、红外光谱、核磁共振氢谱、核磁共振碳谱、质谱等手段对其结构进行了表征. 用X射线单晶衍射测定了化合物2a, 2b和2c的晶体结构. 2a属于单斜晶系, C2/c空间群, 晶胞参数a＝1.88282(6) nm, b＝0.86541(3) nm, c＝1.90766(6) nm, β＝95.5830(10)°, V＝3.09362 nm³, Z＝8, R＝0.064, wR＝0.170. 2b属于单斜晶系, P2₁/n空间群, 晶胞参数 a＝1.28261(10) nm, b＝0.89942(7) nm, c＝1.46896(12) nm, β＝104.217(1)°, V＝1.6427(2) nm³, Z＝4, R＝0.055, wR＝0.165. 2c属于三斜晶系, P-1空间群, 晶胞参数a＝0.84613(11) nm, b＝0.98923(13) nm, c＝1.14305(15) nm, β＝96.002(2)°, V＝0.9326 nm³, Z＝2, R＝0.0684, wR＝0.1795.     

[1-芳基甲羰基-2-(1,2,4-三唑-1-基)]乙基-N,N-二烷基二硫代氨基甲酸酯衍生物的合成、结构表征及生物活性研究

以芳香基三唑类杀菌剂三唑酮为先导物设计并合成了5个含N,N-二烷基二硫代氨基甲酸酯的芳香三唑类化合物, 通过元素分析、红外光谱、核磁共振氢谱和质谱对其结构进行了表征. 用X射线单晶衍射测定了[α-(4-甲氧基苯甲酰基)-2-(1,2,4-三唑-1-基)]乙基-N,N-二甲基二硫代氨基甲酸酯的晶体结构, 晶体属于三斜晶系, 空间群, 晶胞参数为: a＝0.73482(15) nm, b＝1.1051(2) nm, c＝1.1209(2) nm, α＝90.32(3)°, β＝101.97(3)°, γ＝105.13(3)°, V＝0.8578(3) nm³, Z＝2, D_c＝1.357 g/cm³, F(000)＝368, µ＝0.324 mm^－1. 生物测试结果显示这5种有机化合物都具有杀菌性和植物生长调节活性     

N-取代苯甲酰基-N'-取代芳基硫脲的合成、晶体结构及生物活性

为了寻找新的高活性农药, 利用工业易得的三氟羧草醚及其中间体为起始原料, 设计合成了9个未见报道的N-取代苯甲酰基-N'-取代芳基硫脲化合物, 结构经IR, ¹H NMR, 元素分析确认. X射线衍射测定了化合物4b的晶体结构, 结果表明: 其分子属于三斜晶系, 空间群P-1, a＝0.51588(19) nm, b＝1.0766(4) nm, c＝2.0596(8) nm, α＝81.113(6)°, β＝89.702(6)°, γ＝78.131(6)°, V＝1.1056(7) nm³, D_c＝1.445 Mg/m³, Z＝2, F(000)＝492, μ＝0.319 mm^－1. 初步生物活性测试结果表明, 部分化合物具有较好的除草活性.     

N-乙氧羰基-N'-3-吡啶基硫脲的合成及其超分子晶体结构

以N,N,N',N'-四甲基乙二胺(TMEDA)为催化剂, 通过氯甲酸乙酯与硫氰酸钾反应合成了中间体乙氧羰基异硫氰酸酯, 后者不需分离直接与3-氨基吡啶反应, 得到N-乙氧羰基-N'-3-吡啶基硫脲. 该产物用EA, IR, ¹H NMR进行了表征, 经X射线单晶衍射法确定了其单晶结构, 晶体结构表明, 晶体属于单斜晶系, P2(1)/c空间群, 晶胞参数: a＝1.0333(6) nm, b＝0.7118(4) nm, c＝1.5160(8) nm, α＝γ＝90.00°, β＝98.517(8)°, V＝1.1028(10) nm³, Z＝4. 晶体中硫脲分子通过分子间氢键的相互作用形成了一维链状超分子结构, 由于范德华力作用形成沿b轴延伸的层状结构.     

N-对氯苯基氮杂15冠5八钼多酸钠超分子配合物的结构与热分解

本文对新型超分子配合物［Na(N-(p-ClPh)-15-C-5(Et₂O)］₂N₂Mo₈O₂₆进行了X-射线四圆衍射测定，该晶体属单斜晶系，空间群为P2₁/c,a=1.7803(4), b=1.3674(3), c=1.4610(3)(nm), β=112.33(2)°, 相似文献   

新型含吡唑基的查尔酮的合成、表征及晶体结构

以2种1-苯基-3-甲基-5-对甲苯氧基-吡唑-4-甲醛为原料, 在强碱条件下与苯乙酮(取代苯乙酮)发生羟醛缩合, 高产率地合成出10种新型含吡唑基的查尔酮. 化合物的结构经元素分析, IR和¹H NMR确认. 并用X射线衍射法测定了化合物4c的晶体结构. 化合物4c属三斜晶系, 空间群P-1, 晶胞参数: a＝1.0225(2) nm, b＝1.4263(3) nm, c＝1.6718(3) nm, α＝110.32(3)°, β＝106.30(3)°, γ＝98.11(3)°, M_r＝428.90, V＝2.1159(7) nm³, D_c＝1.346 Mg/m³, Z＝2, F(000)＝896.     

Preparation and Crystal Structure of a New Uranyl Sulfate Templated by a Bis-isothiouronium Cation

Crystals of a new uranyl sulfate (C₂N₄H₈S₂)[UO₂(SO₄)₂] · 0.3H₂O ( 1 ) templated by a relatively rare bis-isothiouronium cation, were formed upon evaporation of aqueous solutions containing uranyl acetate, thiourea, and excess sulfuric acid. The new compound is orthorhombic, P2₁2₁2₁, a = 6.928(2) Å, b = 13.398(3) Å, c = 15.225(3) Å, Z = 2. Its crystal structure is comprised of [UO₂(SO₄)₂] moieties linked by hydrogen bonds formed between the template cations and terminal oxygen atoms of the sulfate tetrahedra. The C₂N₄H₈S₂²⁺ template is most likely formed in situ during a redox reaction between uranyl cation and thiourea in a strongly acidic medium, with UO₂²⁺ partially reduced to U⁴⁺.     

Hybrid Inorganic‐Organic Frameworks: Synthesis and Crystal Structures of RbFe(SO4)(C2O4)0.5·H2O and CsM(SO4)(C2O4)0.5·H2O (M = Mn,Fe)

Three new alkali metal transition metal sulfate‐oxalates, RbFe(SO₄)(C₂O₄)_0.5 · H₂O and CsM(SO₄)(C₂O₄)_0.5 · H₂O (M = Mn, Fe) were prepared through hydrothermal reactions and characterized by single‐crystal X‐ray diffraction, solid state UV/Vis/NIR diffuse reflectance spectroscopy, infrared spectra, thermogravimetric analysis, and powder X‐ray diffraction. The title compounds all crystallize in the monoclinic space group P2₁/c (no. 14) with lattice parameters: a = 7.9193(5), b = 9.4907(6), c = 8.8090(6) Å, β = 95.180(2)°, Z = 4 for RbFe(SO₄)(C₂O₄)_0.5 · H₂O; a = 8.0654(11), b = 9.6103(13), c = 9.2189(13) Å, β = 94.564(4)°, Z = 4 for CsMn(SO₄)(C₂O₄)_0.5 · H₂O; and a = 7.9377(3), b = 9.5757(4), c = 9.1474(4) Å, β = 96.1040(10)°, Z = 4 for CsFe(SO₄)(C₂O₄)_0.5 · H₂O. All compounds exhibit three‐dimensional frameworks composed of [MO₆] octahedra, [SO₄]^2– tetrahedra, and [C₂O₄]^2– anions. The alkali cations are located in one‐dimensional tunnels.     

Syntheses and Structures of Na2Mg3(OH)2(SO4)3·4H2O and K2Mg3(OH)2(SO4)3·2H2O

The crystal structures of Na₂Mg₃(OH)₂(SO₄)₃ · 4H₂O and K₂Mg₃(OH)₂(SO₄)₃ · 2H₂O, were determined from conventional laboratory X‐ray powder diffraction data. Synthesis and crystal growth were made by mixing alkali metal sulfate, magnesium sulfate hydrate, and magnesium oxide with small amounts of water followed by heating at 150 °C. The compounds crystallize in space group Cmc2₁ (No. 36) with lattice parameters of a = 19.7351(3), b = 7.2228(2), c = 10.0285(2) Å for the sodium and a = 17.9427(2), b = 7.5184(1), c = 9.7945(1) Å for the potassium sample. The crystal structure consists of a linked MgO₆–SO₄ layered network, where the space between the layers is filled with either potassium (K⁺) or Na⁺‐2H₂O units. The potassium‐bearing structure is isostructural to K₂Co₃(OH)₂(SO₄)₃ · 2(H₂O). The sodium compound has a similar crystal structure, where the bigger potassium ion is replaced by sodium ions and twice as many water molecules. Geometry optimization of the hydrogen positions were made with an empirical energy code.     

非对称双(均三唑席夫碱)衍生物的合成及抗肿瘤活性

为寻找新结构的水溶性抗癌先导化合物, 采用氨基均三唑硫代苯丙酮(1)与氨基均三唑硫醇(2a～2e)缩合得双均三唑单席夫碱化物3a～3e, 接着依次与氨基氯乙烷和水杨醛进行亲核取代和缩合反应, 分别得到含碱性侧链的单席夫碱4a～4e和非对称双席夫碱5a～5e. 所合成新化合物的结构经元素分析和光谱数据表征, 用甲基四噻唑蓝比色法(MTT)对新化合物进行了对于CHO, HL60和L1210 3种癌细胞株的体外活性试验. 在合成的15个新化合物中, 双席夫碱结构的抗癌活性最强, 其IC₅₀值在20.0 μmol•L^－1以下, 尤其是均三唑环连有双供电子取代基时(如化合物5c), 表现出潜在的活性, 其抗癌活性与上市药物比生群相当, 具有侯选药物研究的价值.     

N-烷基/芳基-N'-(4-芳基噻唑-2-基)-N"-糖基胍的合成及生物活性研究

2,3,4,6-四-O-乙酰基-β-D-吡喃葡萄糖基异硫氰酸酯(1)与2-氨基-4-取代苯基噻唑(2a～2b)反应, 生成糖基硫脲衍生物3a～3b, 再在伯胺存在下经氯化汞脱硫, 得到一系列新的N-烷基/芳基-N'-(4-芳基噻唑-2-基)-N"-糖基胍类化合物(4a～4e, 5a～5e). 所有新化合物的结构均经IR, ¹H NMR, MS谱和元素分析证实, 所得产物均为β-构型. 生物活性测试结果表明, 化合物4b和5d对HIV-1 PR表现出了较高的抑制活性.     

胍基木吡喃糖苷的合成及其抗HIV蛋白酶活性

2,3,4-三-O-乙酰基-b-D-木吡喃糖基异硫氰酸酯1与2-氨基-4/6-取代-苯并噻唑2a～2e反应, 生成糖基硫脲衍生物3a～3e, 再在伯胺存在下经氯化汞脱硫, 得到一系列新的胍基木吡喃糖苷类化合物4a～4e, 5a～5e, 6a～6e, 7a～7e, 所有新化合物的结构均经IR, ¹H NMR, MS谱和元素分析证实, 所得产物均为β-构型. 生物活性测试结果表明, 化合物4c, 5b, 6b～6d, 7b等对HIV-1蛋白酶表现出了较高的抑制活性.     

SDS抑制乙酰胆碱酯酶反应的热动力学研究

在37 ℃, pH＝7.4的Tris-HCl缓冲体系中, 利用热焓放大技术和热动力学初始速率法研究了近生理条件下的乙酰胆碱酯酶(AchE)催化溴化乙酰胆碱水解反应及十二烷基硫酸钠(SDS)对反应的抑制动力学. 通过测量实验条件下反应体系的总反应焓及相同条件下的Tris碱的质子化焓, 确定了酶反应的摩尔反应焓ΔH_m,1为0.63 kJ•mol^－1, 米氏常数K_m和底物抑制常数K_S分别为0.85～0.94 mmol•L^－1和0.74～0.83 mmol•L^－1. SDS能够显著地降低反应速率, 但对酶反应的生化常数的影响较小, SDS对AchE的抑制表现为不可逆抑制. 在一定浓度的SDS溶液中, AchE的失活符合一级反应动力学规律, 表观一级失活速率常数与作用时间及SDS浓度的四次方呈线性关系, 失活常数为(2.47～2.69)×10¹³ mol^－4•L⁴•min^－1.     

Crystal structure of 1-methyl-1,3,5,7-tetraazaadamantan-1-ium ammonium sulfate hydrate,a double salt containing puckered layers of hydrogen-bonded NH 4 + and SO 4 2− groups

The double salt [(CH₂)₆N₄CH₃](NH₄)SO₄·H₂O crystallizes in space groupP2₁/a, witha=12.994(2),b=6.319(1),c=15.082(2) Å, =93.78(2)^o, andZ=4. The structure was solved by the heavy-atom method and refined toR _F ²=0.051 for 2478 MoK data. The ammonium and sulfate ions are cross-linked by hydrogen bonds to form puckered layers disposed about the (001) family of planes. Each water molecule bridges a [(CH₂)₆N₄CH₃]⁺ ion and a sulfate group, so that the organic cations lying on both sides of a puckered layer have their methyl groups pointing inward and fitting into depressions. Supplementary Data relating to this article are deposited with the British Library as Supplementary Publication No. SUP 82063 (18 pages).Carried out, in part, under contract DE-AC02-76CH00016 with the U.S. Department of Energy, Office of Basic Energy Sciences.     

The Borosulfate Story Goes on—From Alkali and Oxonium Salts to Polyacids

The structural principles of borosulfates derived from the B/S ratio are confirmed and extended to new representatives of this class showing novel motifs. According to the composition, Na[B(S₂O₇)₂] (P2₁/c; a=10.949(6), b=8.491(14), c=12.701(8) Å; β=110.227(1)°; Z=4) and K[B(S₂O₇)₂] (Cc; a=11.3368(6), b=14.662(14), c=13.6650(8) Å; β=94.235(1)°; Z=8) contain isolated [B(S₂O₇)₂]^? ions, in which the central BO₄ tetrahedron is coordinated by two disulfate units. The alkali cations have coordination numbers of 7 (Na) and 8 (K), respectively. The structure of Cs[B(S₂O₇)(SO₄)] (P2₁/c; a=10.4525(6), b=11.3191(14), c=8.2760(8) Å; β=103.206(1); Z=4) combines, for the first time, sulfate and disulfate units into a chain structure. Cs has a coordination number of 12. The same structural units were found in H[B(S₂O₇)(SO₄)] (P2₁/c; a=15.6974(6), b=11.4362(14), c=8.5557(8) Å; β=90.334(3)°; Z=8). This compound represents the first example of a polyacid. The hydrogen atoms were located and connect the chains to form layers through hydrogen‐bonding bridges. H₃O[B(SO₄)₂] (P4/ncc; a=9.1377(6), c=7.3423(8) Å; Z=4) is the first oxonium compound of this type to be found. The BO₄ tetrahedra are linked by SO₄ tetrahedra to form linear chains similar to those in SiS₂. The chains form a tetragonal rod packing structure with H₃O⁺ between the rods. The structures of borosulfates can be classified following the concept described by Liebau for silicates, which was extended to borophosphates by Kniep et al. In contrast to these structures, borosulfates do not comprise B‐O‐B bonds but instead contain S‐O‐S connections. All compounds were obtained as colourless, moisture‐sensitive single crystals by reaction of B₂O₃ and the appropriate alkali salt in oleum.     

Synthesis of Fused Isolated Azoles and N-Heteroaryl Derivatives Based on 2-Methyl-3,4-dihydrothieno[3,4-d]pyrimidin-5-amine

In this work, we report the synthesis and characterization of new compounds derived from thieno[d]pyrimidines. The formation of isolated and fused thieno[d]pyrimidine derivatives was achieved via reacting 5-amino-(2-methyl)thieno[3,4-d]pyrimidin-4(3H)-one (3) with some selected reagents. The starting compound (2) was prepared in a quantitative yield using a modified procedure by conversion of the cyano group in 1 to the amide via hydrolysis using concentrated H₂SO₄. Methylthieno[3,4-d]pyrimidin-5-yl (8, 9, and 18), 3-phenylthieno[3,4-e][1,2,4]triazolo[4,3-c]pyrimidines (11–15) and tetrazolo[1,5-c]thieno[3,4-e]pyrimidine (16) have been synthesized in excellent isolated yield. The interaction of N-acetyl derivative 19 with benzaldehyde and/or some nitroso compounds afforded the chalcones and Schiff's bases derivatives 20 and 26a and c respectively. The latter compounds were used as key intermediates in the synthesis of N-acetylpyrazol-3-yl (21a and 21b), 6-phenylpyrimidine-2-(one)thione (22a and b), pyrazolo-1-carbothioamide (25), and thiazolidinone andβ β-lactam derivatives 28a and 28c and 30a and 30c respectively. The structures of these compounds were established by elemental analysis, infrared (IR), mass spectrometry (MS), and NMR spectral analysis.